By incorporating the protein tumor marker AFP, which retained the benefits of current clinical methods, and employing sWGS to detect the whole genomic CNA and FS profiles, we aimed to detect the genomic‐level changes and to reduce processing time and costs, particularly for analyzing cancer tissue. The gene discussed is AFP; the disease is neoplasm.